The Trump administration filed a motion Jan. 27 asking a federal court in Louisiana to pause a lawsuit that seeks to reimpose restrictions on the abortion pill mifepristone while the FDA conducts a new review of the drug’s safety and…
Pharmacy
The Department of Health and Human Services issued a special advisory bulletin clarifying that pharmaceutical manufacturers may sell lower-cost prescription drugs directly to Medicare and Medicaid patients without violating the Anti-Kickback Statute, provided that specific safeguards are met. The guidance,…
Eli Lilly has entered a global research collaboration and licensing agreement with Seamless Therapeutics to develop programmable recombinase-based gene therapies for genetic hearing loss. Under the deal, Lilly secured exclusive rights to site-specific recombinases programmed by Seamless to target gene…
More than 850,000 members of Horizon NJ Health, the managed Medicaid plan operated by Horizon Blue Cross Blue Shield of New Jersey, will lose in-network access to CVS pharmacies after April 30. The insurer is advising affected members to transfer…
CMS will negotiate the prices for Trulicity, Biktarvy and 13 other high-cost medications commonly covered by Medicaid Parts B and D, according to a Jan. 27 news release from the agency. The Medicare Drug Price Negotiation Program enacted its first…
Advertisement
The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit hyperactivity disorder across all age groups. Centanafadine is being reviewed under priority status, with a Prescription…
As cell and gene therapies move into mainstream care, pharmacy leaders say health systems are confronting a shared reality: While they may be clinically prepared, their infrastructure might be insufficient — especially in terms of financing, coordination and sustainability for…
The 340B program stands at a critical crossroads in 2026. With the recent court-ordered pause of the rebate pilot program and HHS’s decision to “go back to the drawing board,” covered entities have gained valuable breathing room, but fundamental challenges…
Delays at the pharmacy counter and going “back-and-forth” with a health plan or provider are the top challenges for patients filling prescriptions, according to a national survey. Surescripts, a health information network focused on electronic prescriptions, partnered with The Harris…
Michael Dejos, PharmD, is joining Atlanta-based Emory Healthcare as corporate director of medication safety. From September 2019 to July 2025, Dr. Dejos was the system medication safety officer of Memphis, Tenn.-based Methodist Le Bonheur Healthcare, according to his LinkedIn profile.…